Germany-based Cellbox Solutions has secured €5 million in total Series A funding after completing the final stage of its investment round. The company will use the money to strengthen its business and develop new logistics services for transporting sensitive biological materials.
Cellbox Solutions initially raised around €3.5 million in March 2026. The latest closing brings the total funding raised in the Series A round to €5 million, giving the company more resources to support its growth plans.
The funding round received backing from additional investors, including members of Baltic Business Angels Invest GmbH. Existing backers NRW.BANK and Fraunhofer Venture also took part in the latest investment.
“Over the past years, we have built a strong foundation for the controlled transport of living biological materials,” says Prof. Dr. Kathrin Adlkofer, founder and CEO of Cellbox Solutions. “With the successful completion of our Series A round, we are now expanding our established warm-chain technology platform into a broader offering for physiological logistics. This will allow us to support customers more comprehensively across their logistics workflows and expand our presence in key international markets.”
“Completion of the Series A gives us additional resources to scale the commercial model behind our technology. By expanding rental and recurring service offerings and combining them with transportation, monitoring, and complementary logistics services, we can build longer-term customer relationships and a more scalable service model across markets. Our focus is now on translating the strength of the Cellbox platform into sustainable commercial growth,” adds Dr. Bernd Muehlenweg, CBO and CFO of Cellbox Solutions.
Founded in 2017, Cellbox Solutions is a logistics technology company based in Cologne, Germany. It helps healthcare and life sciences companies transport sensitive biological materials and medicines that must be kept at controlled temperatures and cannot be frozen.
The company has developed a portable CO₂ incubator called Cellbox. It creates a controlled environment for transporting living cells, organoids, tissues and other sensitive biological materials. Users can adjust the temperature and CO₂ levels to keep these materials in suitable conditions during transport.
Cellbox Solutions’ technology is used worldwide in scientific research, clinical studies and advanced medical treatments. Its systems help maintain stable conditions while transporting biological materials, supporting research teams and healthcare organisations that work with these sensitive products.
